12 research outputs found
Restoring the Balance: The Patentability of DNA-Related Technology in the US and Europe
- Publication venue
- 'Elsevier BV'
- Publication date
- 01/01/2009
- Field of study
Belimumab
- Author
- Cambridge Antibody Technology Group PLC.
- GlaxoSmithKline
- GlaxoSmithKline
- GlaxoSmithKline Inc
- GlaxoSmithKline plc Human Genome Sciences Inc.
- Human Gene Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences Inc.
- Human Genome Sciences.
- HumanGenome Sciences Inc.
- JT Merrill
- Lupus Foundation of America.
- M Petri
- M Petri
- MedImmune Inc.
- R Furie
- R Furie
- S B Navarra
- W Stohl
- WBG Halpern
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
The Impact of Mass School Immunization on School Attendance
- Author
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study
An update on pharmacotherapeutic strategies for obesity
- Author
- Acosta A
- AstraZeneca
- Food and Drug Administration
- Frias JP
- Hales CM
- Lilly E
- MedImmune LLC
- Novartis Pharmaceuticals
- Novartis Pharmaceuticals
- Novartis Pharmaceuticals
- Novo Nordisk A/S
- Novo Nordisk A/S
- Novo Nordisk A/S
- Novo Nordisk A/S
- Novo Nordisk A/S
- Novo Nordisk A/S
- Novo Nordisk A/S
- Novo Nordisk A/S
- Novo Nordisk A/S
- Novo Nordisk A/S
- Orexigen Therapeutics Inc
- Wadden T
- Wadden TA
- Publication venue
- 'Informa UK Limited'
- Publication date
- Field of study
Ustekinumab and Anti-Interleukin-23 Agents in Crohn's Disease
- Author
- AbbVie Inc
- Abraham
- Adedokun
- Adedokun
- Aggarwal
- Badat
- Batista
- Battat
- Becker
- Ben-Horin
- Ben-Horin
- Benson
- Billioud
- Boehringer Ingelheim Inc
- Campa
- Chackerian
- Croxford
- Deepak
- Deepak
- Deepak
- Ding
- Eli Lilly and Company
- Fahmy
- Feagan
- Feagan
- Feagan
- Feagan
- Gheita
- Goldminz
- Gratton
- Greenup
- Griffiths
- Guenova
- Harris
- Hinchey
- Janssen Research & Development LLC
- Khorrami
- Kleinschek
- Kobayashi
- Kopylov
- Kuehbacher
- Leonardi
- Levin
- Lieberman
- Ma
- Mahadevan
- Mannon
- Martin
- McConnell
- McInnes
- MedImmune LLC
- Neurath
- Nguyen
- Niederreiter
- Ordas
- Papamichael
- Papp
- Papp
- Papp
- Papp
- Parakkal Deepak
- Parham
- Presky
- Ritchlin
- Rubin
- Rudner
- Ryan
- Ryan
- Sandborn
- Sandborn
- Sandborn
- Sandborn
- Sandborn
- Sandborn
- Sandborn
- Sands
- Sands
- Sands
- Schaufelberg
- Segal
- Singh
- Strober
- Sun Pharma and Merck & Co. Inc
- Terdiman
- Tillack
- Toedter
- Trinchieri
- Uhlig
- Wang
- William J. Sandborn
- Wils
- Xavier
- Zhou
- Zhu
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study